Arkadios Wealth Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,241
| Closed | -$345K | – | 933 |
|
|
2024
Q2 | $345K | Sell |
2,241
-553
| -20% | -$85.2K | 0.02% | 587 |
|
|
2024
Q1 | $430K | Sell |
2,794
-224
| -7% | -$34.4K | 0.03% | 421 |
|
|
2023
Q4 | $477K | Sell |
3,018
-27
| -0.9% | -$4.27K | 0.04% | 378 |
|
|
2023
Q3 | $446K | Sell |
3,045
-333
| -10% | -$48.7K | 0.04% | 370 |
|
|
2023
Q2 | $517K | Sell |
3,378
-468
| -12% | -$71.7K | 0.06% | 296 |
|
|
2023
Q1 | $596K | Sell |
3,846
-177
| -4% | -$27.4K | 0.07% | 275 |
|
|
2022
Q4 | $620K | Buy |
+4,023
| New | +$620K | 0.08% | 253 |
|
|
2022
Q3 | – | Sell |
-1,563
| Closed | -$212K | – | 537 |
|
|
2022
Q2 | $212K | Sell |
1,563
-73
| -4% | -$9.9K | 0.03% | 491 |
|
|
2022
Q1 | $244K | Sell |
1,636
-168
| -9% | -$25.1K | 0.03% | 473 |
|
|
2021
Q4 | $292K | Buy |
1,804
+207
| +13% | +$33.5K | 0.04% | 452 |
|
|
2021
Q3 | $265K | Buy |
1,597
+149
| +10% | +$24.7K | 0.04% | 434 |
|
|
2021
Q2 | $249K | Buy |
1,448
+296
| +26% | +$50.9K | 0.03% | 483 |
|
|
2021
Q1 | $184K | Buy |
1,152
+1,049
| +1,018% | +$168K | 0.03% | 429 |
|
|
2020
Q4 | $17K | Buy |
+103
| New | +$17K | ﹤0.01% | 801 |
|
|
2020
Q3 | – | Sell |
-95
| Closed | -$16.4K | – | 1038 |
|
|
2020
Q2 | $16.4K | Buy |
+95
| New | +$16.4K | 0.01% | 583 |
|